Home > PP>
Biography

Dr. Seong S. Shim
Louis Stokes Cleveland V.A. Medical Center, USA

Email: Seong.Shim@va.gov, sshim1121@yahoo.com

Qualifications
1994  Fellowship, Schizophrenia Research Program, Yale University
1992  Residency, Yale University, School of Medicine
1991  Residency, Southern Illinois University, School of Medicine
1989  Ph.D., Southern Illinois University, School of Medicine
1980  M.D, Chung-Ang University, Medical College
1975  B.A, Chung-Ang University, Medical College


Publications (Selected)

  1. Shim S.S., Becker R.E.: Roles of monoamine oxidase A and B in metabolism ofserotonin within serotonergic neurons. J Psychopharmacol 1993;7:181-189.Shim S.S., Shi X.-S., Bunney B.S.: Effects of Lesions in the Medial Prefrontal Cortex on the Activity of Midbrain Dopamine Neurons. Neuropsychopharmacolgy1996;15:437-441.
  2. Shim S.S.: Action of atypical antipsychotics (letter). Am J Psychiatry2002;159:154-155.
  3. Shim S.S., Adityanjee: Is NMDA receptor hypofunction in schizophrenia associatedwith a primary hyperglutamatergic state? (letter). Arch General Psychiatry2002;59:466-468.
  4. Shim S.S., Adityanjee: Extrapyramidal symptoms associated with quetiapine. AustNZ J of Psychiatry 2003;37:773.
  5. Shim S.S., Hammonds M., Ganocy S.J., Calabrese J.R.: Effects of lithium exposureon synaptic plasticity in the dentate gyrus of the hippocampus. ProgNeuropsychopharmacol Biol Psychiat 2007;31:343-347.
  6. Hammonds M.D., Shim S.S., Pingfu F., Calabrese J.R.: Effects of subchroniclithium treatment on levels of BDNF, Bcl-2 and phospho-CREB in the rathippocampus. Basic Clin Pharmacol Toxicol 2007;100:356-359.
  7. Nocjar C., Hammonds M.D., Shim S.S.: Chronic lithium treatment magnifieslearning in rats. Neuroscience 2007;150:774-788.
  8. Shim S.S., Hammonds M.D., Kee B.S.: Potentiation of the NMDA receptor in thetreatment of schizophrenia: focused on the glycine site. Eur Arch Psychiatry ClinNeurosci 2007;258:16-27.
  9. Gao K., Kemp D.E., Ganocy S., Shim S.S., Findling R.: Calabrese J.R.: DifferentialInteractions between Comorbid Anxiety and Substance Use Disorder in RapidCycling Bipolar I or II Disorder. J Affect Disord. 2008;110:167-173.
  10. Shim S.S., Hammonds M.D, Vrabel M.M.:Augmentation of Behavioral Therapywith Glycine Agonists for Obsessive-Compulsive Disorder (letter). Am J Psychiatry2008;165:150.
  11. Hammonds M.D., Shim, S.S.: Effects of 4 weeks lithium and olanzapine treatmenton levels of BDNF, Bcl-2 and phosphorylated CREB in the hippocampus Basic ClinPharmacol Toxicol 2009;105:113–119.
  12. Shim S.S.: Lower Serum levels of lithium may produce efficacy without adverseeffects (letter). Am J Geriat Psychiat 2009;17:625.
  13. Shim S. S.: Treatment-Resistant Schizophrenia: Strategies for RecognizingSchizophrenia and Treating to Remission. Psychiatric Times August, 2009.

Profile Details

NULL